Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Nasopharyngeal Carcinoma × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Recruiting 4 Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasms 7 Carcinoma, Hepatocellular 5 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 3 Colorectal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Head and Neck Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Myositis 1 Metastatic Colorectal Adenocarcinoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hyperthermia 1 Histiocytoma, Malignant Fibrous 1 Heart Diseases 1 Glioma 1 Eye Diseases 1 Esophageal Squamous Cell Carcinoma 1 Endocrine System Diseases 1 Digestive System Neoplasms 1

Interventions

Cisplatin 19 Radiotherapy, Intensity-Modulated 10 Fluorouracil 9 Gemcitabine 6 Docetaxel 6 Cetuximab 5 Capecitabine 5 pembrolizumab 4 nimotuzumab 3 nedaplatin 3 Radiation 3 Carboplatin 3 toripalimab 2 camrelizumab 2 anlotinib 2 Radiotherapy 2 Paclitaxel 2 Dexamethasone 2 Chemoradiotherapy 2 spartalizumab 1 raltitrexed 1 icotinib 1 fosaprepitant 1 famitinib 1 endostar protein 1 cc-486 1 bintrafusp alfa protein, human 1 apatinib 1 Vorinostat 1 TP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03984357 2025-07-17

PLATINUM

Sun Yat-sen University

Phase 2 Completed

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡